Cocaine Got $300 More Expensive an Ounce. Nobody's Demand Went Anywhere — It Went Shopping.

Jonathan Kirkpatrick has sold methamphetamine for close to twenty years — most of that time from inside Washington Corrections Center, where he is currently incarcerated. He also writes for Filter Magazine, under his own name, as a peer harm-reduction educator explaining the drug economy from the only vantage point that actually sees all of it: the supply side. His argument about fentanyl contamination in cocaine isn’t sentimental — it’s logistical. Powders get bagged with the same equipment, in the same rooms, by people moving fast and getting paid by weight. Contamination isn’t usually a plot. It’s a rounding error in somebody else’s supply chain.

That same unsentimental logic explains something odd happening in South Florida right now, and it’s worth sitting with because it cuts against almost everything the word “addiction” is supposed to mean.

Nobody in Palm Beach County got more dependent on methamphetamine this month. Cocaine got roughly $300 more expensive an ounce, and the underlying demand for a stimulant didn’t vanish — it went shopping.

The switch is a spreadsheet, not a craving

In the first ten days of July, DEA agents in Palm Beach County seized 54 kilograms of methamphetamine in two separate busts — an amount Special Agent Kevin Bobbitt told WFLX he had “never seen” in his career working South Florida. His explanation wasn’t pharmacological. It was arithmetic: cocaine was running $600 to $1,000 an ounce on the street, while methamphetamine was going for $280 to $500. “Much cheaper to get your hands on methamphetamine,” Bobbitt said — and cost-sensitive users, people who need a stimulant and don’t have brand loyalty to a specific one, followed the price. Jim Tichy, who runs The Lodge at Delray Beach recovery home, told the same station his admissions are “coming in younger and younger” — a downstream signal of a cheaper, more available drug reaching people earlier in their using careers, not a sign that meth itself became more addictive overnight.

Two months earlier and ninety minutes south, the opposite price signal was making the opposite kind of news. DEA Miami told Local10 that wholesale cocaine — $10,000 to $13,000 a kilo — had hit its lowest price in the agency’s 22-year local record, and Broward Health ER physician Dr. Edmara Nieves described what that abundance looks like on a gurney: “A lot of times we have patients that we can’t even wake them up.” Read side by side, Palm Beach’s meth surge and Miami’s cocaine glut aren’t a contradiction. They’re two snapshots of the same underlying stimulant market two months and ninety miles apart, sloshing between whichever drug the supply chain has made cheapest that week.

If you have ever switched from one drug to whatever was cheaper and easier to find that week, you already understand this isn’t really a meth story or a cocaine story. It’s a budget. And it’s worth asking what that does to the way we talk about “addiction” as a fixed relationship between one person and one chemical, when the actual behavior on the ground looks a lot more like substitution economics than brand devotion.

The supply side isn’t obeying the enforcement story

The Trump administration has claimed its lethal boat-interdiction campaign — Operation Southern Spear, 67 strikes and 221 people killed as of late July — has “virtually ended” seaborne cocaine trafficking. A previously unreported DEA assessment, reported by the Washington Post on July 27, found the opposite: no measurable reduction in cocaine’s U.S. availability, purity, or street price. Pentagon spokesman Sean Parnell disputed the agency’s own read. That gap between the political claim and the internal assessment matters for the same reason the Palm Beach price data matters — it says supply is the variable actually moving the stimulant market, not enforcement theater, and definitely not some population-wide surge in cravings. The UN’s 2026 World Drug Report backs that read at global scale: cocaine production hit a record above 4,000 tonnes, up from 3,708 tonnes in 2023, with roughly 25 million users worldwide, up from 17 million in 2013 — a supply and demand curve rising together, independent of any single country’s interdiction headlines.

A previously unreported DEA assessment, reported by the Washington Post on July 27, found the opposite: no measurable reduction in cocaine’s U.S.

The same drug, priced differently by whose neighborhood cooked it

None of this is new, and that’s the part that should sting. The federal government has known for forty years that how a stimulant gets treated has more to do with who’s using it than what it does to a brain. The Anti-Drug Abuse Act of 1986 set a 100-to-1 sentencing ratio between crack and powder cocaine — the same drug, chemically, in two forms associated with two different classes of user. Five grams of crack, disproportionately found in poorer Black communities, triggered the same mandatory five-year sentence as 500 grams of powder, associated with wealthier white users. The Fair Sentencing Act cut that ratio to 18-to-1 in 2010; the First Step Act made the fix retroactive in 2018. It still wasn’t close to equal: from 2015 to 2023, roughly 80% of federal crack-cocaine convictions were of Black defendants, versus 6% white and 13% Latino. The chemistry never changed. The zip code did.

That history is the frame for reading Columbia neuroscientist Carl Hart’s long-standing, still-contested argument that 80 to 90% of cocaine and crack users are not dependent in any clinical sense, and that what looks like an “addiction crisis” is usually a poverty and context crisis wearing addiction’s name. The Palm Beach switch is a small, current data point in Hart’s favor: people didn’t get more hooked on stimulants in July. They got priced out of one and into another, the same way anyone changes brands when the one they know gets expensive. Researchers Daniel Ciccarone and Nabarun Dasgupta have made a related point in 2026 commentary — that naming a crisis after whichever single drug is cheapest this year (meth crisis, cocaine crisis) obscures a faster-moving reality: supply, price, and adulteration are converging and shifting underneath users faster than the labels can keep up. The data backs the speed of that shift — stimulant-involved overdoses that also involved fentanyl rose from 0.6% of all U.S. overdose deaths in 2010 to 32.3% in 2021, a fiftyfold increase, concentrated as cocaine-plus-fentanyl in the Northeast and meth-plus-fentanyl in the South and West — the same geography, in other words, as Palm Beach and Miami’s two different price shocks.

None of this erases the real physical toll of heavy stimulant use — the sleeplessness, the cardiac strain, the psychosis that can follow a sustained run, the very real reason Dr. Nieves can’t wake some of her patients. But it does mean the honest question isn’t “why is meth so addictive” or “why is cocaine so addictive.” It’s why a $300-an-ounce price gap can move an entire regional market overnight, and what that says about how thin the line is between “user” and “whoever the supply chain reaches this month.” If you’re the one making that switch, or watching someone you love make it, the useful thing to know is that it’s not a character failure clocking in — it’s a market doing exactly what markets do, and the psychology of dependency has always had more to do with access and context than with which specific powder happened to be cheapest the week it started.